+28.2%
MRNA vs ACM
-22.3%
+50.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ACM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -3.1% | -0.3% | -1.3% |
| 7D | -10.1% | -3.7% | -6.4% | -7.8% |
| 30D | +126.7% | -12.7% | +139.4% | +135.7% |
| 3M | +184.1% | -9.8% | +193.9% | +190.5% |
| 6M | +143.3% | -31.4% | +174.7% | +178.1% |
| YTD | +359.9% | -32.1% | +391.9% | +421.8% |
| 1Y | +454.2% | -47.8% | +502.0% | +619.2% |
| All | +28.2% | -22.3% | +50.5% | +30.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ACM.
Daily Out/Under-Performance
Portfolio return minus ACM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ACM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ACM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling